scanX
Torrent Pharmaceuticals
add_icon

Torrent Pharmaceuticals

3,785.90
-9.80
(-0.26%)
Market Cap
₹1,28,132.10 Cr
PE Ratio
58.80
Volume
1,97,257.00
Day High - Low
₹3,805.10 - ₹3,756.00
52W High-Low
₹3,882.20 - ₹2,886.45
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,28,132.10 Cr
EPS
56.47
PB Ratio
14.89
Book Value
249.66
EBITDA
3,744.30
Dividend Yield
0.16 %
Industry
Healthcare
Sector
Pharmaceuticals
ROE Growth %
-
Debt to Equity
0.50
Analyst Rating and Forecast
- By Refinitiv from28 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+71.43 %
+71.43 %
Hold
Hold+21.43 %
+21.43 %
Sell
Sell+7.14 %
+7.14 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Torrent Pharmaceuticals Acquires Additional Stake in J.B. Chemicals Through Open Offer1 day ago
Torrent Pharmaceuticals acquired 1,317 equity shares of J.B. Chemicals & Pharmaceuticals Limited on December 5, 2025, at INR 1,639.18 per share through an open offer to public shareholders. The acquisition was conducted under SEBI takeover regulations, continuing Torrent's previously announced plan to increase its stake in the pharmaceutical company.
neutral
Torrent Pharmaceuticals Block Trade Worth Rs. 88.09 Crores on NSE2 days ago
Torrent Pharmaceuticals executed a block trade on NSE involving 231,969 shares at Rs. 3,797.50 per share, totaling Rs. 88.09 crores. The transaction represents a significant institutional trade in the pharmaceutical company's shares at the specified price level.
negative
Torrent Pharmaceuticals Faces ₹41.33 Crore GST Penalty Over Export Refund Dispute9 days ago
Joint Commissioner of Central GST, Ahmedabad South imposed a penalty of ₹41,33,84,165 on Torrent Pharmaceuticals under Section 74 of the Central GST Act, 2017 for alleged erroneous refund on export of goods. The company plans to file an appeal and expects no material financial impact, expressing confidence in a favorable outcome.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,805.30
#1 4,33,151.90
40.68
#1 54,729.00
9.71
#1 10,980
2.89
63.65
Divis Laboratories
6,473.50
1,71,851.10
69.05
9,712.00
18.67
2,191
35.10
50.10
Torrent Pharmaceuticals
3,785.90
#3 1,28,132.10
#9 58.80
#9 11,539.40
#9 6.99
#10 1,911
#4 30.46
60.01
Cipla
1,520.80
1,22,843.20
22.73
28,409.50
7.12
5,291
3.71
48.01
Dr Reddys Laboratories
1,275.20
1,06,429.90
#1 18.15
33,741.20
16.73
5,725
-0.38
61.42
Lupin
2,098.80
95,863.60
21.34
22,909.50
13.74
3,306
#1 72.75
67.65
Zydus Life Science
931.45
93,725.70
18.56
23,511.00
18.55
4,615
34.60
40.18
Mankind Pharma
2,205.50
91,033.90
52.05
12,744.20
#1 20.90
2,007
-21.05
32.30
Aurobindo Pharma
1,217.60
70,718.40
20.70
32,345.60
9.43
3,484
3.81
58.88
Alkem Laboratories
5,675.50
67,859.10
28.29
13,458.30
3.70
2,216
10.98
53.12

Automatic Screeners on ScanX

Community
5% near 52 Week High
Growth Rate
Revenue Growth
6.99 %
Net Income Growth
15.39 %
Cash Flow Change
-20.85 %
ROE
4.22 %
ROCE
1.42 %
EBITDA Margin (Avg.)
2.17 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
1,234
1,961
1,728
1,573
1,501
1,539
1,449
1,463
1,485
1,453
1,467
1,508
1,708
1,861
1,868
1,951
1,839
1,996
2,002
1,977
1,927
2,018
1,991
1,980
1,954
2,160
2,154
2,142
2,160
2,322
2,277
2,449
2,461
2,582
2,654
2,746
2,726
2,839
2,815
2,795
2,891
3,091
3,219
Expenses
992
1,035
976
1,118
1,016
1,114
1,099
1,127
1,139
1,077
1,088
1,104
1,344
1,395
1,421
1,490
1,740
1,481
1,464
1,426
1,398
1,395
1,382
1,388
1,355
1,457
1,477
1,570
2,055
1,635
1,612
1,767
1,764
1,800
1,835
1,863
1,862
1,955
1,950
1,895
2,019
2,146
2,232
EBITDA
242
926
752
455
485
425
350
336
346
376
379
404
364
466
447
461
99
515
538
551
529
623
609
592
599
703
677
572
105
687
665
682
697
782
819
883
864
884
865
900
872
945
987
Operating Profit %
13 %
45 %
41 %
26 %
31 %
26 %
22 %
20 %
18 %
20 %
22 %
23 %
19 %
24 %
24 %
24 %
5 %
25 %
26 %
26 %
27 %
31 %
30 %
30 %
29 %
31 %
30 %
25 %
2 %
29 %
29 %
28 %
28 %
29 %
30 %
31 %
31 %
31 %
31 %
31 %
31 %
31 %
31 %
Depreciation
60
57
59
59
63
68
69
73
97
80
84
94
151
150
152
156
160
160
163
163
168
161
165
167
165
165
168
167
162
155
163
193
196
191
201
213
203
197
198
199
201
201
204
Interest
47
55
48
43
38
49
51
48
58
56
51
80
121
122
126
133
123
122
116
111
102
102
92
91
73
68
71
62
57
55
69
102
107
103
91
80
80
75
64
57
56
56
48
Profit Before Tax
155
875
681
377
410
346
253
245
244
266
272
259
134
232
205
275
-150
279
296
319
293
402
384
357
383
484
472
357
-87
532
463
419
433
531
559
631
631
656
661
691
665
738
791
Tax
25
225
172
87
126
54
46
16
38
78
68
201
-94
69
26
29
2
63
52
68
-21
81
74
60
59
154
156
108
31
178
151
127
146
153
173
188
182
199
208
188
167
190
200
Net Profit
130
650
509
290
284
292
207
229
206
188
204
58
228
163
179
246
-152
216
244
251
314
321
310
297
324
330
316
249
-118
354
312
292
287
378
386
443
449
457
453
503
498
548
591
EPS in ₹
7.70
38.40
30.01
17.19
16.82
17.28
12.25
13.47
12.17
11.08
12.07
3.37
13.55
9.66
10.57
14.50
-8.95
12.74
14.48
14.77
18.56
18.98
18.32
17.52
19.16
19.53
18.63
14.75
-6.97
20.90
9.22
8.63
8.48
11.18
11.39
13.10
13.27
13.51
13.37
14.88
14.71
16.19
17.54
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
7,904
9,058
9,702
14,243
14,121
14,010
14,075
13,100
15,012
15,061
14,990
Fixed Assets
2,833
2,859
3,688
7,855
7,748
7,533
7,065
6,423
8,122
8,138
7,947
Current Assets
4,051
4,688
4,880
5,262
5,038
4,979
5,522
5,165
5,314
5,612
5,623
Capital Work in Progress
678
1,042
520
647
617
712
889
630
765
361
478
Investments
298
780
804
492
353
2
181
226
199
173
156
Other Assets
4,095
4,378
4,691
5,249
5,403
5,763
5,940
5,821
5,926
6,389
6,409
Total Liabilities
7,904
9,058
9,702
14,243
14,121
14,010
14,075
13,100
15,012
15,061
14,990
Current Liabilities
2,824
3,286
2,738
5,202
5,165
5,454
4,892
4,415
5,447
5,425
4,717
Non Current Liabilities
2,589
2,278
2,613
4,418
4,231
3,732
3,346
2,732
3,367
2,779
2,682
Total Equity
2,491
3,495
4,351
4,623
4,724
4,823
5,837
5,953
6,198
6,856
7,591
Reserve & Surplus
2,406
3,410
4,266
4,538
4,640
4,739
5,753
5,868
6,029
6,687
7,422
Share Capital
85
85
85
85
85
85
85
85
169
169
169
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-90
438
18
-366
238
73
-89
-174
110
327
-262
Investing Activities
-2,113
-870
-798
-4,677
-246
229
-444
-196
-2,335
-160
-549
Operating Activities
810
2,742
1,009
894
1,798
1,393
2,005
1,803
2,368
3,266
2,585
Financing Activities
1,212
-1,435
-193
3,417
-1,314
-1,549
-1,651
-1,781
77
-2,780
-2,298
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Jul 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
68.31 %
68.31 %
68.31 %
68.31 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
14.14 %
14.22 %
14.46 %
16.17 %
16.31 %
16.09 %
15.92 %
DIIs
6.53 %
6.71 %
6.76 %
6.78 %
7.52 %
7.82 %
7.76 %
8.89 %
8.87 %
9.00 %
8.31 %
7.16 %
6.44 %
7.26 %
7.27 %
7.08 %
8.35 %
8.35 %
8.65 %
9.28 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
7.89 %
7.72 %
7.58 %
7.29 %
7.25 %
7.10 %
7.13 %
4.59 %
4.73 %
4.47 %
4.38 %
4.25 %
4.15 %
4.09 %
3.98 %
4.34 %
4.61 %
4.51 %
4.44 %
4.08 %
Others
14.33 %
14.33 %
14.42 %
14.68 %
13.98 %
13.83 %
13.86 %
15.27 %
15.16 %
15.28 %
16.07 %
17.34 %
18.16 %
3.27 %
3.28 %
2.87 %
2.56 %
2.52 %
2.50 %
2.41 %
No of Share Holders
0
72,616
64,525
64,309
67,205
63,229
62,933
64,557
67,866
63,831
61,572
69,612
69,117
71,154
74,765
79,848
85,035
86,005
81,856
78,226

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 14 14 17 32 35 48 22 28 32
Dividend Yield (%) 0.00 2.24 1.44 1.72 2.51 2.51 3.12 0.85 0.87 0.85

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
16 Feb 2021 DIVIDEND Dividend
₹ 20.00 /share
 15 Feb 2021 1,376.03 1,303.15
18 Jun 2021 DIVIDEND Dividend
₹ 15.00 /share
 17 Jun 2021 1,382.38 1,476.95
03 Feb 2022 DIVIDEND Dividend
₹ 25.00 /share
 02 Feb 2022 1,552.43 1,367.98
06 Jun 2022 DIVIDEND Dividend
₹ 15.00 /share
 03 Jun 2022 1,296.25 1,390.33
06 Jun 2022 DIVIDEND Dividend
₹ 8.00 /share
 03 Jun 2022 1,296.25 1,390.33
11 Jul 2022 BONUS Bonus
1:1
 08 Jul 2022 1,441.88 1,466.70
03 Feb 2023 DIVIDEND Dividend
₹ 14.00 /share
 03 Feb 2023 1,584.65 1,541.05
23 Jun 2023 DIVIDEND Dividend
₹ 8.00 /share
 23 Jun 2023 1,705.95 1,862.65
12 Feb 2024 DIVIDEND Dividend
₹ 22.00 /share
 12 Feb 2024 2,512.50 2,657.35
21 Jun 2024 DIVIDEND Dividend
₹ 6.00 /share
 21 Jun 2024 2,691.80 2,858.10
23 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 23 Jul 2024 2,840.45 3,028.80
25 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 25 Oct 2024 3,557.25 3,317.25
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Jan 2025 3,274.45 3,266.20
01 Feb 2025 DIVIDEND Dividend
₹ 26.00 /share
 31 Jan 2025 3,266.20 3,259.20
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 20 May 2025 3,237.70 3,302.80
20 Jun 2025 DIVIDEND Dividend
₹ 6.00 /share
 20 Jun 2025 3,302.80 3,164.00
28 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 28 Jul 2025 3,521.85 3,603.80
28 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 28 Jul 2025 3,334.10 3,603.80
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 07 Nov 2025 3,578.35 3,554.50

Announcements

Announcement under Regulation 30 (LODR)-Updates on Acquisition1 day ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20159 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication9 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Partial Redemption Of Commercial Papers Issued Under ISIN INE685A07124Nov 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated 07-Nov-25Nov 07, 2025
Results For Quarter And Half Year Ended 30-Sep-25Nov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 27, 2025
Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 27, 2025
Announcement Under Regulation 20 Of SEBI LODROct 21, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 07, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 07, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Oct 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 03, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 30, 2025
Closure of Trading WindowSep 29, 2025
Redemption Of Commercial Papers Issued Under ISIN INE685A14153Sep 26, 2025
Intimation Regarding Issue Of Commercial PapersSep 24, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionSep 23, 2025
Redemption Of Commercial Papers Issued Under ISIN: INE685A14146Sep 18, 2025
Intimation Regarding Issue Of Commercial PapersSep 17, 2025
Announcement under Regulation 30 (LODR)-AcquisitionSep 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 05, 2025
Announcement Under Reg 30Aug 02, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 31, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 28, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 28, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated 28-Jul-25Jul 28, 2025
Results For Quarter Ended 30-Jun-25Jul 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 21, 2025
Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 21, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) Letter To Shareholders - Integrated Annual Report FY 2024-25Jul 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 05, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 04, 2025
Reg. 34 (1) Annual Report.Jul 04, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 01, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJun 30, 2025
Closure of Trading WindowJun 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJun 29, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HDFC Large Cap Fund Direct-Growth
0.00%
-3180904
-2.85%
-2.84%
Axis Large Cap Fund Direct-Growth
0.00%
-946972
-1.00%
-1.04%
Franklin India Large Cap Fund Direct-Growth
0.00%
-846654
-3.80%
-3.98%
UTI Flexi Cap Fund Direct-Growth
0.00%
-742000
-1.03%
-1.06%
Kotak Small Cap Fund Direct-Growth
0.00%
-463748
-0.92%
-0.96%
Canara Robeco Large Cap Fund Direct-Growth
0.00%
-407164
-0.84%
-0.89%
SBI Healthcare Opportunities Fund Direct Plan-Growth
0.00%
-400000
-3.49%
-3.66%
ICICI Prudential Nifty Next 50 Index Direct-Growth
0.00%
-364534
-1.59%
-1.66%
HDFC Large and Mid Cap Fund Direct- Growth
0.00%
-336766
-0.42%
-0.45%
Axis ELSS Tax Saver Direct Plan-Growth
0.00%
-330930
-0.34%
-0.35%
Nippon India Value Fund Direct-Growth
0.00%
-328626
-1.28%
-1.35%
Axis Large & Mid Cap Fund Direct-Growth
0.00%
-312176
-0.72%
-0.75%
UTI Nifty Next 50 Index Fund Direct - Growth
0.00%
-266164
-1.59%
-1.66%
Aditya Birla Sun Life Consumption Direct Fund-Growth
0.00%
-219869
-1.20%
-1.16%
Mirae Asset Healthcare Fund Direct - Growth
0.00%
-215716
-2.72%
-2.81%
HDFC Pharma And Healthcare Fund Direct - Growth
0.00%
-200598
-3.63%
-3.81%
UTI Dividend Yield Fund Direct-Growth
0.00%
-190000
-1.73%
-1.89%
Aditya Birla Sun Life Value Direct Fund-Growth
0.00%
-176902
-1.00%
-1.06%
Tata Aggressive Hybrid Fund Direct-Growth
0.00%
-176100
-1.51%
-1.58%
Aditya Birla Sun Life Multi Asset Allocation Fund Direct-Growth
0.00%
-172131
-1.23%
-1.32%
Kotak Large Cap Fund Direct-Growth
0.00%
-170025
-0.56%
-0.59%
Tata India Pharma & Healthcare Fund Direct-Growth
0.00%
-168394
-4.52%
-4.68%
HDFC Innovation Fund Direct-Growth
0.00%
-157578
-2.06%
-2.19%
Helios Flexi Cap Fund Direct - Growth
0.00%
-156729
-1.13%
-1.29%
Bandhan Nifty100 Low Volatility 30 Index Fund Direct-Growth
0.00%
-152459
-2.96%
-3.10%

Technical Indicators

RSI(14)
Neutral
60.01
ATR(14)
Less Volatile
64.13
STOCH(9,6)
Neutral
58.98
STOCH RSI(14)
Neutral
46.11
MACD(12,26)
Bearish
-2.65
ADX(14)
Weak Trend
22.68
UO(9)
Bearish
52.06
ROC(12)
Uptrend And Accelerating
1.46
WillR(14)
Neutral
-35.31
Bearish
4
Neutral
4
Bullish
1

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited is a leading Indian pharmaceutical company with a global presence. It specializes in cardiovascular, central nervous system, vitamins and nutrients, gastro-intestinal, and anti-diabetes therapies. The company operates through wholly-owned subsidiaries in over 40 countries, with major operations in the US, Germany, and Brazil. Torrent Pharmaceuticals has manufacturing facilities in multiple Indian states and an R&D center in Ahmedabad. Founded in 1959, the company has grown through acquisitions, expansions, and product launches. It has entered various therapeutic segments including dermatology, gynecology, and oncology. Torrent Pharmaceuticals is engaged in research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations both domestically and internationally.
Website
https://www.torrentpharma.com
Chairperson NameSamir Mehta
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104